CD8A and melanoma: CD8+ T cells were increased in the TILs in the TME of BRafV600E/Ptennull/Mi-2βnull melanomas and the increase was significantly augmented by the treatment of anti-PD-1 antibody (Supplementary Fig. 2d, e).